3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (14) , 3864-3867
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine ReceptorJournal of Medicinal Chemistry, 2004
- Interleukin-8 receptor antagonists in pulmonary diseasesCurrent Opinion in Pharmacology, 2001
- Allergen-Stimulated Leukotriene B4 and Interleukin-8 Levels in Patients with Asthma and Allergic Rhinitis-Modulation by a Lipid Pathway InhibitorAnnals of Allergy, Asthma & Immunology, 1998
- Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil MigrationJournal of Biological Chemistry, 1998
- Involvement of interleukin-8 in dialysis-related arthritisKidney International, 1998
- Granulocyte chemotactic protein 2 acts via both IL- 8 receptors, CXCR1 and CXCR2European Journal of Immunology, 1998
- Neutrophil and B Cell Expansion in Mice That Lack the Murine IL-8 Receptor HomologScience, 1994
- Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.Journal of Experimental Medicine, 1991
- Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 ReceptorScience, 1991
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991